Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cytek Biosciences Sees FY2025 Sales $204.000M-$212.000M vs $219.60M Est

Author: Benzinga Newsdesk | February 27, 2025 05:24pm
Cytek Biosciences (NASDAQ:CTKB) sees FY2025 sales of $204.000 million-$212.000 million vs $219.60 million analyst estimate.

Posted In: CTKB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist